Foster City, CA, United States of America

Yvonne Chinn

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2016-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Cheyenne, WY (US) (2018)
  • Foster City, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yvonne Chinn: Innovator in Antibody Development

Introduction

Yvonne Chinn is a prominent inventor based in Foster City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of four patents to her name, her work has the potential to impact various therapeutic applications.

Latest Patents

Yvonne's latest patents include innovative inventions such as anti-Jagged2 antibodies and methods of use. This invention provides anti-Jagged2 antibodies and outlines methods for utilizing them effectively. Additionally, she has developed anti-Jagged1 antibodies and methods of use, which also focus on the therapeutic applications of these antibodies.

Career Highlights

Yvonne Chinn is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to contribute to groundbreaking research and development in the field of antibody therapies.

Collaborations

Some of Yvonne's notable coworkers include Julie Q Hang and Christian W Siebel. Their collaboration has likely fostered a productive environment for innovation and research within their projects.

Conclusion

Yvonne Chinn's contributions to antibody development exemplify her dedication to advancing biotechnology. Her patents and work at Genentech highlight her role as a key innovator in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…